I apologize. I was just trying to follow the implications.
In a previous session, the committee approved G-14.1, I believe, which required ministers to publish, as soon as possible, a notice stating the name of anybody granted a waiver. The waiver process is intended to complement the risk assessment process to assess new substances, which is a time-bound process. That's a process managed by risk assessment officials.
This amendment, as I understand it, would interject an implied expectation that the government develop regulations prescribing processes for meaningful public participation in decisions about granting a waiver. That seems to contradict the obligation that was passed to grant waivers “as soon as possible”.
We're wrestling with the implications.